Outcomes in Patients With Metastatic TNBC and Their Association With HER2 and Trop-2 Expression Status
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
J. Clin. Oncol 2024 Feb 29;[EPub Ahead of Print], A Bardia, HS Rugo, SM Tolaney, D Loirat, K Punie, M Oliveira, A Brufsky, K Kalinsky, J Cortés, JO Shaughnessy, V Diéras, LA Carey, L Gianni, M Piccart-Gebhart, S Loibl, OK Yoon, Y Pan, S Hofsess, SC Phan, SA HurvitzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.